Eli Lilly and Company (NYSE:LLY) has withdrawn its supplemental New Drug Application (sNDA) from the U.S. Food and Drug Administration (FDA) for Cymbalta(R) (duloxetine HCl) for the management of chronic pain.

continue reading.....

Young women who have a miscarriage or an abortion are three times more likely to experience a drug or alcohol problem during their lifetime, according to new research published in the December issue of the British Journal of Psychiatry. Recent evidence has suggested that induced abortion may be associated with later psychiatric disorders in women.

continue reading.....

A group of researchers has identified the precise mechanisms by which binge drinking contributes to clogs in arteries that lead to heart attack and stroke, according to a study published today in the journal Atherosclerosis. The works adds to a growing body of evidence that drinking patterns matter as much, if not more, to risk for cardiovascular disease than the total amount consumed.

continue reading.....

The use of injection drugs is responsible for about two-thirds of HIV cases in Russia, the country’s consumer rights and sanitary oversight agency announced at a press conference on Monday, AFP/Yahoo! News reports. Alexandre Golyussov, head of HIV/AIDS prevention at the agency, said, “AIDS is mainly spreading in Russia among drug addicts, while sexual transmission is the second main cause.

continue reading.....

WHAT: A special telebriefing with renowned brain and behavior researchers who will headline the 2008 American College of Neuropsychopharmacology’s Annual Meeting WHO: Bill Carlezon, PhD, Chair of ACNP’s Public Information Committee Roger Pittman, MD, Harvard Medical School/Mass.

continue reading.....

Eli Lilly and Company (NYSE: LLY) has withdrawn its supplemental New Drug Application (sNDA) from the U.S. Food and Drug Administration (FDA) for Cymbalta(R) (duloxetine HCl) for the management of chronic pain. Lilly plans to resubmit the application in the first half of 2009, adding data from a recently completed positive study in chronic osteoarthritis pain of the knee.

continue reading.....

Researchers from EKB Technology - a spinout joint venture between the University of Oxford and C-Tech Innovation - have announced positive results from an elegant method of improving mammalian cell bioreactors. Bioreactors are used to manufacture proteins for medicines, and the researchers have show that a mild electric field can successfully extract unwanted by-product chemicals from the bioreactor.

continue reading.....

continue reading.....

Find out why pet turtles may be a health risk and how FDA is enforcing a ban on the small creatures.

continue reading.....

Be careful about the three main types of interactions: drugs with food and beverages, drugs with dietary supplements, and drugs with other drugs.

continue reading.....